MarmontAM,DamasioEE,BacigalupoA,et al.A to O bone marrow transplantation in severe aplastic anemia: Dynamics of blood group conversion and demonstration of early dyserythropoiesis in the engrafted marrow. Br J Haematol 1977;36:511-8.10.1111/j.1365-2141.1977.tb00991.xSearch in Google Scholar
Bryant E,Martin PJ. Documentation of engraftment and characterization of chimerism following hematopoietic cell transplantation. In: Blume KG, Forman S, Appelbaum FR, eds. Thomas’ hematopoietic cell transplantation. 3rd ed. Malden, Mass: Blackwell Publishing, 2004:234-43.Search in Google Scholar
Benson K, Fields K, Hiemenz J,et al. The plateletrefractory bone marrow transplant patient: prophylaxis and treatment of bleeding. Semin Oncol 1993;20(5):102-9.Search in Google Scholar
Ishida A, Handa M,Wakui M, Okamoto S, Kamakura M, Ikeda Y. Clinical factors inf luencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation—a prospective analysis. Transfusion 1998;38:839-47.10.1046/j.1537-2995.1998.38998409004.xSearch in Google Scholar
O’Donnell MR. Blood group incompatibilities and haemolytic complications of hematopoietic cell transplantation. In: Blume KG, Forman S, Appelbaum FR, eds. Thomas’ hematopoietic cell transplantation. 3rd ed. Malden, Mass: Blackwell Publishing, 2004:824.Search in Google Scholar
Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia, PA: Churchill Livingstone, 2004:459-60.10.1016/B978-0-443-08559-8.50016-9Search in Google Scholar
Warkentin PI, Yomtovian R, Hurd D, et al. Severe delayed hemolytic transfusion reaction complicating an ABO-incompatible bone marrow transplantation. Vox Sang 1983;45:40-7.10.1111/j.1423-0410.1983.tb04120.xSearch in Google Scholar
Lee JH, Lee JH, Choi SJ, et al. Changes of isoagglutinin titers after ABO-incompatible allogeneic stem cell transplantation. Br J Haematol 2003;120:702-10.10.1046/j.1365-2141.2003.04128.xSearch in Google Scholar
Bolan CD, Leitman SF, Griffith LM, et al. Delayed donor RBC chimerism and pure RBC aplasia following major ABO-incompatible nonmyelo-ablative hematopoietic stem cell transplantation. Blood 2001;98:1687-94.10.1182/blood.V98.6.1687Search in Google Scholar
Bar BM, Van Djik BA, Schattenberg A, de Man AJ, Kunst VA, de Witte T. Erythrocyte repopulation after major ABO-incompatible transplantation with lymphocyte-depleted bone marrow. Bone Marrow Transplant 1995;16:793-9.Search in Google Scholar
Gmur J, Burger J, Schaffner A, et al. Pure RBC aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 1990;75:290-5.10.1182/blood.V75.1.290.290Search in Google Scholar
Sniecinsky IJ, Oien L, Petz LD, Blume KG. Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 1988;45:530-4.10.1097/00007890-198803000-00005Search in Google Scholar
Witherspoon RP, Storb R, Ochs HD, et al. Recovery of antibody production in human allogeneic marrow graft recipients: inf luence of time posttransplantation, the presence or absence of graft-versus-host disease, and antithymocyte globulin treatment. Blood 1981;58:360-8.10.1182/blood.V58.2.360.360Search in Google Scholar
Ramsey G, Sherman LA. Transfusion therapy in solid organ transplantation. Hematol Oncol Clin North Am 1994;8:1117-29.10.1016/S0889-8588(18)30125-4Search in Google Scholar
Hows J, Beddow K, Gordon-Smith E, et al. Donor-derived RBC antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood 1986;67:177-81.10.1182/blood.V67.1.177.177Search in Google Scholar
Rowley S, Braine H. Probable hemolysis following minor ABO incompatible marrow transplantation (IMT) (abstract). Blood 1982;60(Suppl. 1):171.Search in Google Scholar
Gajewski JL, Petz LD, Calhoun L, et al. Hemolysis of transfused O RBCs in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Blood 1992;79:3076-85.10.1182/blood.V79.11.3076.bloodjournal79113076Search in Google Scholar
Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia, PA: Churchill Livingstone, 2004:463-4.10.1016/B978-0-443-08559-8.50012-1Search in Google Scholar
Sokol RJ, Stamps R, Booker DJ, et al. Posttransplant immune-mediated hemolysis.Transfusion 2002;42: 198-204.10.1046/j.1537-2995.2002.00026.x11896335Search in Google Scholar
Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia, PA: Churchill Livingstone, 2004:465.10.1016/B978-0-443-08559-8.50012-1Search in Google Scholar
Bensinger WI, Buckner CD, Thomas ED, Clift RA. ABO-incompatible marrow transplants. Transplantation 1982;33:427-9.10.1097/00007890-198204000-000177041368Search in Google Scholar
Korbling M, Huh YO, Durett A, et al. Allogeneic blood stem cell transplantation: peripheralization and yield of primitive donor-derived hematopoietic progenitor cells (CD341 Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995;86:2842-8.10.1182/blood.V86.7.2842.2842Search in Google Scholar
Ramsey G. RBC antibodies arising from solid organ transplants. Transfusion 1991;31:76-86.10.1046/j.1537-2995.1991.31191096190.x1986468Search in Google Scholar
Salmon JP, Michaux S, Hermanne JP, et al. Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion 1999;39:824-7.10.1046/j.1537-2995.1999.39080824.x10504116Search in Google Scholar
Bolan CD, Childs RW, Procter JL,Barrett AJ, Leitman SF. Massive haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO-incompatibility B J Haematol 2001;112:787-95.10.1046/j.1365-2141.2001.02587.x11260085Search in Google Scholar
Yomtovian R, Chau CJ, Hendrix D, et al. Lack of isohemagglutinin production following minor ABO incompatible umbilical cord blood transplantation (abstract). Transfusion 2002;42:1s-2s.Search in Google Scholar
Sandmaier BM, Storb R. Nonmyeloablative therapy and hematopoietic cell transplantation for hematologic disorders. In: Blume KG, Forman S, Appelbaum FR, eds. Thomas’ hematopoietic cell transplantation. 3rd ed. Malden, Mass: Blackwell Publishing, 2004:1164-76.Search in Google Scholar
Worel N, Greinix HT, Keil F, et al. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning. Transfusion 2002;42:1293-1301.10.1046/j.1537-2995.2002.00209.xSearch in Google Scholar
Mielcarek M, Zaucha JM, Sandmaier B, et al. Type of post-grafting immunosuppression after non-myeloablative blood cell transplantation may influence risk of delayed haemolysis due to minor ABO incompatibility. Br J Haematol 2002;116:500-1.10.1046/j.1365-2141.2002.03268.xSearch in Google Scholar
Greeno EW, Perry EH, Ilstrup SJ, Weisdorf DJ. Exchange transfusion the hard way: Massive hemolysis following transplantation of bone marrow with minor ABO incompatibility. Transfusion 1996;36:71-4.10.1046/j.1537-2995.1996.36196190519.xSearch in Google Scholar
Benjamin RJ, Anton JH. ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity. Transfusion 1999;39:1273-4.10.1046/j.1537-2995.1999.39111273.xSearch in Google Scholar
Kollman C, Howe CW, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001; 98:2043-51.10.1182/blood.V98.7.2043Search in Google Scholar
Mielcarek M, Leisenring W, Torok-Storb B, Storb R. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood 2000; 96:1150-6.10.1182/blood.V96.3.1150Search in Google Scholar
Heal J, Kenmotsu N, Rowe JM, Blumberg N. A possible survival advantage in adults with acute leukemia receiving ABO-identical platelet transfusions. Am J Hematol 1994;45:189-90.10.1002/ajh.2830450219Search in Google Scholar
Benjamin RJ, McGurk S, Ralston MS, Churchill WH, Antin JH. ABO-incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion 1999;39:179-87.10.1046/j.1537-2995.1999.39299154733.xSearch in Google Scholar
Goldman J, Liesveld J, Nichols D, Heal J, Blumberg N. ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation. Leuk Res 2003;27:489-91.10.1016/S0145-2126(02)00259-XSearch in Google Scholar
Stussi G, Muntwyler J, Passweg JR, et al. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantations. Bone Marrow Transplant 2002;30:87-93.10.1038/sj.bmt.170362112132047Search in Google Scholar
Mehta J, Powles R, Sirohi B, et al. Does donorrecipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia? Bone Marrow Transplant 2002;29:853-9.10.1038/sj.bmt.170354512058235Search in Google Scholar
Storb R, Thomas ED, Weiden PL, et al. Aplastic anemia treated by allogeneic bone marrow transplantation: A report on 49 new cases from Seattle. Blood 1976;48:817-41.10.1182/blood.V48.6.817.817Search in Google Scholar
Lasky L,Warkentin P, Ramsey N, Kersey J, McGlave P, McCullough J. Hemotherapy in patients undergoing blood group incompatible bone marrow transfusion. Transfusion 1983;23:277-85.10.1046/j.1537-2995.1983.23483276858.x6410549Search in Google Scholar
Bacigalupo A,Van Lint MT, Occhini D, et al. ABO compatibility and acute graft-versus-host disease allogeneic bone marrow transplantation. Transplantation 1988;45:1091-4.10.1097/00007890-198806000-000183289150Search in Google Scholar
Barone B, Cordeiro de Paiva TM, da Silva Bouzas LF. ABO system incompatibility and graft versus host disease (GVHD) frequency in bone marrow transplanted patients (abstract). Blood 2001;98: 374b.Search in Google Scholar
Ting A,Pun A, Dodds AJ, Atkinson K, Biggs JC. RBC alloantibodies produced after bone marrow transplantation. Transfusion 1987;27:145-7.10.1046/j.1537-2995.1987.27287150186.x3547785Search in Google Scholar
De la Rubia J, Arriaga F, Andreu R, et al. Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor? Transfusion 2001;41:106-110.Search in Google Scholar
Franchini M, Gandini G, Aprili G. Non-ABO RBC alloantibodies after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004;33:1169-72.10.1038/sj.bmt.170452415094753Search in Google Scholar
Young PP, Goodnough LT,Westervelt P, DiPersio JF. Immune hemolysis involving non-ABO/RhD alloantibodies following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001;27:1305-10.10.1038/sj.bmt.170307411548850Search in Google Scholar
Warkentin PI, Hilden JM, Kersey JH, Ramsey NKC, McCullough J. Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch. Vox Sang 1985;48:89-104.10.1111/j.1423-0410.1985.tb00152.x2416122Search in Google Scholar
Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia, PA: Churchill Livingstone, 2004:468.10.1016/B978-0-443-08559-8.50012-1Search in Google Scholar
Chen FE, Owen I, Savage D, et al. Late onset haemolysis and RBC autoimmunisation after allogeneic bone marrow transplant. Bone Marrow Transplant 1997;19:491-5.10.1038/sj.bmt.17006779052917Search in Google Scholar
Drobyski WR, Potluri J, Sauer D, Gottschall JL. Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 1996:17:1093-9.Search in Google Scholar
O’Brien TA, Eastlund T, Peters C,et al. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases. Br J Haematology (in press).Search in Google Scholar
